![Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years - Journal of Geriatric Oncology Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years - Journal of Geriatric Oncology](https://www.geriatriconcology.net/cms/asset/3962673a-095c-43cf-baf1-2e4c79ed2bd3/gr1.jpg)
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years - Journal of Geriatric Oncology
![Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2388-1/MediaObjects/41419_2020_2388_Fig3_HTML.png)
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease
![Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2388-1/MediaObjects/41419_2020_2388_Fig2_HTML.png)
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease
Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy | PLOS Computational Biology
![Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants](https://ebm.bmj.com/content/ebmed/26/3/98/F2.large.jpg)
Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants
![CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies - The Lancet Haematology CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies - The Lancet Haematology](https://www.thelancet.com/cms/attachment/16e2634e-3679-4361-9fb7-ec7189202d1f/gr1_lrg.jpg)
CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies - The Lancet Haematology
![Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia | Science Translational Medicine Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3008226/asset/c43d9f08-5223-4722-a2b9-7aa1dc1dcbf2/assets/graphic/6-224ra25-f1.jpeg)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia | Science Translational Medicine
![Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2388-1/MediaObjects/41419_2020_2388_Fig4_HTML.png)
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease
![Successful CD19 CAR T Cell Therapy Requires Prior Lymphodepletion Mice... | Download Scientific Diagram Successful CD19 CAR T Cell Therapy Requires Prior Lymphodepletion Mice... | Download Scientific Diagram](https://www.researchgate.net/publication/321909787/figure/fig5/AS:659965517783041@1534359449837/Successful-CD19-CAR-T-Cell-Therapy-Requires-Prior-Lymphodepletion-Mice-bearing.png)